• Je něco špatně v tomto záznamu ?

Nitric oxide elevation in polytrauma is driven by oxygen radicals

E. Beitl, A. Baňasová, D. Miková, V. Hampl

. 2017 ; 66 (Supplementum 4) : S561-S565. [pub] 2017Dec30

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19030479

A common problem in management of polytrauma - a simultaneous injury to more than one organ or organ system, at least one of them lethal without intervention - is a discrepancy between a relatively good initial state and a serious subsequent development. Since nitric oxide (NO) is produced in high quantities during tissue injury, we assumed that serum levels of NO (and its oxidation products, NOx) might serve as a prognostic marker of polytrauma severity. However, we found recently that NOx was increased in polytrauma, but not in the most severe cases. The present study was undertaken to test the hypothesis that serum NOx is reduced in severe polytrauma by concomitant overproduction of reactive oxygen species (ROS). Polytrauma was induced in rats under anesthesia by bilateral fracture of femurs and tibiae plus incision of the right liver lobe through laparotomy. Serum NOx was measured by chemiluminescence after hot acidic reduction. The role of ROS was assessed by treatment with an antioxidant, N-acetyl-L-cysteine (NAC). Experimental polytrauma elevated NOx from 11.0+/-0.7 to 23.8+/-4.5 ppb. This was completely prevented by NAC treatment (9.1+/-2.2 ppb). Serum NOx is elevated in severe polytrauma, and this is not reduced by ROS. On the contrary, ROS are necessary for the NOx elevation, probably because ROS produced by inflammatory cells activated by the polytrauma induce massive NO production.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19030479
003      
CZ-PrNML
005      
20200309151850.0
007      
ta
008      
190830s2017 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933793 $2 doi
035    __
$a (PubMed)29355385
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Beitl, Evžen $7 xx0114400 $u First Orthopaedic Clinic, First Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Nitric oxide elevation in polytrauma is driven by oxygen radicals / $c E. Beitl, A. Baňasová, D. Miková, V. Hampl
520    9_
$a A common problem in management of polytrauma - a simultaneous injury to more than one organ or organ system, at least one of them lethal without intervention - is a discrepancy between a relatively good initial state and a serious subsequent development. Since nitric oxide (NO) is produced in high quantities during tissue injury, we assumed that serum levels of NO (and its oxidation products, NOx) might serve as a prognostic marker of polytrauma severity. However, we found recently that NOx was increased in polytrauma, but not in the most severe cases. The present study was undertaken to test the hypothesis that serum NOx is reduced in severe polytrauma by concomitant overproduction of reactive oxygen species (ROS). Polytrauma was induced in rats under anesthesia by bilateral fracture of femurs and tibiae plus incision of the right liver lobe through laparotomy. Serum NOx was measured by chemiluminescence after hot acidic reduction. The role of ROS was assessed by treatment with an antioxidant, N-acetyl-L-cysteine (NAC). Experimental polytrauma elevated NOx from 11.0+/-0.7 to 23.8+/-4.5 ppb. This was completely prevented by NAC treatment (9.1+/-2.2 ppb). Serum NOx is elevated in severe polytrauma, and this is not reduced by ROS. On the contrary, ROS are necessary for the NOx elevation, probably because ROS produced by inflammatory cells activated by the polytrauma induce massive NO production.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x farmakologie $x terapeutické užití $7 D000975
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a volné radikály $x antagonisté a inhibitory $x krev $7 D005609
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a polytrauma $x krev $x farmakoterapie $7 D009104
650    _2
$a oxid dusnatý $x antagonisté a inhibitory $x krev $7 D009569
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a reaktivní formy kyslíku $x antagonisté a inhibitory $x krev $7 D017382
655    _2
$a časopisecké články $7 D016428
700    1_
$a Baňasová, Alena, $d 1973- $7 xx0074189 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Anaesthesiology and Intensive Care Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Miková, Dana, $d 1962- $7 xx0062462 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hampl, Václav, $d 1962- $7 nlk20030127352 $u Department of Physiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, Supplementum 4 (2017), s. S561-S565
773    0_
$t Proceedings of the ... Physiological days : $g (2017), s. S561-S565 $w MED00183838
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29355385 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20190830 $b ABA008
991    __
$a 20200309152307 $b ABA008
999    __
$a ok $b bmc $g 1440116 $s 1068967
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c Supplementum 4 $d S561-S565 $e 2017Dec30 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2017 $d S561-S565 $m Proceedings of the ... Physiological days $x MED00183838
LZP    __
$b NLK118 $a Pubmed-20190830

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...